Matches in Nanopublications for { ?s ?p "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP807287.RABZp5eaLpyNBgQ53Df2A-J4XtKwQJGqAC9XOUuZ8uhn8130_assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807287.RABZp5eaLpyNBgQ53Df2A-J4XtKwQJGqAC9XOUuZ8uhn8130_provenance.
- NP616018.RAitJCXUC6iAn9-yi-f1t0rD31UsipJhgziDsPrA6LXhM130_assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616018.RAitJCXUC6iAn9-yi-f1t0rD31UsipJhgziDsPrA6LXhM130_provenance.
- assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP880153.RAAuf06QgyVpFP0_PngMbKV_n712Psv4ErC4_tuLureNU130_assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880153.RAAuf06QgyVpFP0_PngMbKV_n712Psv4ErC4_tuLureNU130_provenance.
- NP695844.RAvYrRkSQAQ1_kNp-d0lcIg-Ey3vCqHOACWpyliaL5iPI130_assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695844.RAvYrRkSQAQ1_kNp-d0lcIg-Ey3vCqHOACWpyliaL5iPI130_provenance.
- NP305963.RAOqO49hgAAjXBRff1K88SUeOZwxAXKfskqmTvmIBOgVo130_assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305963.RAOqO49hgAAjXBRff1K88SUeOZwxAXKfskqmTvmIBOgVo130_provenance.
- NP880154.RAzQ2YaDBiAIStb_Cj32f5uavj6wpEP5JIALbK5NSd_Hg130_assertion description "[This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880154.RAzQ2YaDBiAIStb_Cj32f5uavj6wpEP5JIALbK5NSd_Hg130_provenance.